| Substance | Relationship Strength | Studies | Trials | Classes | Roles |
|---|
gallic acid
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid. | 3.27 | 1 | 0 | trihydroxybenzoic acid | antineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite |
phosphoglycolate
phosphoglycolate: RN given refers to parent acid. 2-phosphoglycolic acid : The O-phospho derivative of glycolic acid. | 2.01 | 1 | 0 | carboxyalkyl phosphate | Escherichia coli metabolite;
mouse metabolite |
glycine
[no description available] | 2.03 | 1 | 0 | alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical |
naringenin
[no description available] | 3.27 | 1 | 0 | 4'-hydroxyflavanones;
trihydroxyflavanone | |
palmitic acid
Palmitic Acid: A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.. hexadecanoic acid : A straight-chain, sixteen-carbon, saturated long-chain fatty acid. | 2.01 | 1 | 0 | long-chain fatty acid;
straight-chain saturated fatty acid | algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite |
phenethylamine
phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016. 2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position. | 2.01 | 1 | 0 | alkaloid;
aralkylamine;
phenylethylamine | Escherichia coli metabolite;
human metabolite;
mouse metabolite |
benzamidine
benzamidine: RN given refers to parent cpd. benzamidine : A carboxamidine that is benzene carrying an amidino group. | 2.01 | 1 | 0 | benzenes;
carboxamidine | serine protease inhibitor |
norethindrone
Norethindrone: A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION.. norethisterone : A 17beta-hydroxy steroid that is testosterone in which the hydrogen at position 17 is replaced by an ethynyl group and in which the methyl group attached to position 10 is replaced by hydrogen. | 1.98 | 1 | 0 | 17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol | progestin;
synthetic oral contraceptive |
histidine
Histidine: An essential amino acid that is required for the production of HISTAMINE.. L-histidine : The L-enantiomer of the amino acid histidine.. histidine : An alpha-amino acid that is propanoic acid bearing an amino substituent at position 2 and a 1H-imidazol-4-yl group at position 3. | 2.01 | 1 | 0 | amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid | algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite |
valine
Valine: A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.. valine : A branched-chain amino acid that consists of glycine in which one of the hydrogens attached to the alpha-carbon is substituted by an isopropyl group.. L-valine : The L-enantiomer of valine. | 2.03 | 1 | 0 | L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine | algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite |
tryptophan
Tryptophan: An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals.. tryptophan : An alpha-amino acid that is alanine bearing an indol-3-yl substituent at position 3. | 2.11 | 1 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan | antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite |
xylitol
xylooligosaccharide: structure in first source. pentitol : An alditol obtained by reduction of any pentose.. xylooligosaccharide : An oligosaccharide comprised of xylose residues. | 2.01 | 1 | 0 | | |
nandrolone
Nandrolone: C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.. nandrolone : A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17. | 1.98 | 1 | 0 | 17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid | human metabolite |
flavone
flavone: RN given refers to unlabeled cpd; structure given in first source. flavone : The simplest member of the class of flavones that consists of 4H-chromen-4-one bearing a phenyl substituent at position 2. | 3.27 | 1 | 0 | flavones | metabolite;
nematicide |
glycyl-glycyl-glycine
glycyl-glycyl-glycine : A tripeptide in which three glycine units are linked via peptide bonds in a linear sequence. | 2.03 | 1 | 0 | tripeptide zwitterion;
tripeptide | |
glycylglycine
[no description available] | 2.41 | 2 | 0 | dipeptide zwitterion;
dipeptide | human metabolite |
norgestrienone
Norgestrienone: A synthetic steroid with progestational and contraceptive activities. | 1.98 | 1 | 0 | steroid | estrogen |
3-phenylpropylamine
3-phenylpropylamine : A phenylalkylamine that is benzene in which one of the hydrogens is substituted by a 3-aminopropyl group. | 2.01 | 1 | 0 | benzenes;
phenylalkylamine;
primary amino compound | |
gestrinone
Gestrinone: A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices. | 1.98 | 1 | 0 | oxo steroid | |
1-deoxynojirimycin
1-deoxy-nojirimycin: structure in first source. duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration. | 2.01 | 1 | 0 | 2-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid | anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite |
nitroaniline
nitroaniline: RN given refers to cpd with unspecified locant for nitro moiety. nitroaniline : A substituted aniline that carries one or more nitro groups. | 2.01 | 1 | 0 | | |
abbott 77003
Abbott 77003: a symmetry-based inhibitor of HIV-1 protease | 2.01 | 1 | 0 | | |
amprenavir
[no description available] | 2.01 | 1 | 0 | carbamate ester;
sulfonamide;
tetrahydrofuryl ester | antiviral drug;
HIV protease inhibitor |
epigallocatechin gallate
epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis). (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. | 3.27 | 1 | 0 | flavans;
gallate ester;
polyphenol | antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite |
2-deoxy-2,3-dehydro-n-acetylneuraminic acid
2-deoxy-2,3-dehydro-N-acetylneuraminic acid: also known as NeuAc2en, but this is also synonym for another compound. 2-deoxy-2,3-dehydro-N-acetylneuraminic acid : N-Acetylneuraminic acid reduced across the 2,3-bond with loss of the hydroxy group at C-2; it is a minor component of body fluids although abundant in sialuria. | 2.01 | 1 | 0 | N-acetylneuraminic acids | |
4-fluorobenzylamine
[no description available] | 2.01 | 1 | 0 | | |
brinzolamide
brinzolamide: an antiglaucoma agent | 2.01 | 1 | 0 | sulfonamide;
thienothiazine | antiglaucoma drug;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
glycyl-glycyl-glycyl-glycine
[no description available] | 2.03 | 1 | 0 | | |
malvidin chloride
[no description available] | 3.27 | 1 | 0 | | |
leucyltyrosine
leucyltyrosine: RN given refers to L-Tyr,L-Leu-isomer; RN for cpd without isomeric designation not avail 4/93 | 2.42 | 2 | 0 | dipeptide | metabolite |
tyrosyltyrosine
tyrosyltyrosine: RN given refers to all-(L)-isomer. tyrosyltyrosine : A dipeptide comprising tyrosine with a tyrosyl residue attached to the alpha-nitrogen.. Tyr-Tyr : Tyrosyltyrosine in which each tyrosine residue has L-configuration. | 2.03 | 1 | 0 | tyrosyltyrosine | Mycoplasma genitalium metabolite |
hesperetin
[no description available] | 3.27 | 1 | 0 | 3'-hydroxyflavanones;
4'-methoxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone | antineoplastic agent;
antioxidant;
plant metabolite |
a 76889
A 76889: backbone structure gvien in first source | 2.01 | 1 | 0 | | |
methanesulfonamide
[no description available] | 2.01 | 1 | 0 | | |
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid: precursor of mutagenic nitroso cpd in soy sauce; structure given in first source | 2.11 | 1 | 0 | harmala alkaloid | |
leucylleucine
Leu-Leu : A dipeptide formed from two L-leucine residues. | 2.41 | 2 | 0 | dipeptide;
L-aminoacyl-L-amino acid zwitterion | human metabolite;
Mycoplasma genitalium metabolite |
phenylalanylleucine
phenylalanylleucine: RN given refers to (L)-isomer | 1.98 | 1 | 0 | dipeptide zwitterion;
dipeptide | plant metabolite |
leucyl-alanine
Leu-Ala : A dipeptide composed of L-leucine and L-alanine joined by a peptide linkage. | 1.98 | 1 | 0 | dipeptide | metabolite |
4-phenylbutylamine
4-phenylbutylamine: used as a drug partition into lipid bilayers in a cubic liquid-crystalline phase. 4-phenylbutylamine : A phenylalkylamine that is benzene in which one of the hydrogens is substituted by a 4-aminobutyl group. | 2.01 | 1 | 0 | benzenes;
phenylalkylamine;
primary amino compound | |
eriocitrin
eriocitrin: structure in first source. eriocitrin : A disaccharide derivative that consists of eriodictyol substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | 3.27 | 1 | 0 | 3'-hydroxyflavanones;
4'-hydroxyflavanones;
disaccharide derivative;
flavanone glycoside;
rutinoside;
trihydroxyflavanone | antioxidant |
alanylproline
alanylproline: RN given refers to all (L)-isomer | 2.41 | 2 | 0 | dipeptide zwitterion;
dipeptide | metabolite |
phenylalanylphenylalanylamide
[no description available] | 2.03 | 1 | 0 | | |
tyrosylleucine
[no description available] | 1.98 | 1 | 0 | dipeptide | metabolite |
Trp-Trp
tryptophyltryptophan: an antigelation agent. Trp-Trp : A dipeptide formed from two L-tryptophan residues. | 2.41 | 2 | 0 | dipeptide | Mycoplasma genitalium metabolite |
6-phosphogluconic acid
gluconic acid-6-phosphate: structure. 6-phospho-D-gluconate : A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of 6-phospho-D-gluconic acid.. 6-phospho-D-gluconic acid : A gluconic acid phosphate having the phosphate group at the 6-position. It is an intermediate in the pentose phosphate pathway. | 2.01 | 1 | 0 | gluconic acid phosphate | fundamental metabolite |
glycyltryptophan
glycyltryptophan: RN given refers to (L)-isomer. Gly-Trp : A dipeptide formed from glycine and L-tryptophan residues. | 2.71 | 3 | 0 | dipeptide | metabolite |
glycyltyrosine
Gly-Tyr : A dipeptide composed of glycine and L-tyrosine joined by a peptide linkage. | 2.71 | 3 | 0 | dipeptide | metabolite |
glycylleucine
Gly-Leu : A dipeptide composed of glycine and L-leucine joined by a peptide linkage. | 2.41 | 2 | 0 | dipeptide zwitterion;
dipeptide | metabolite |
alanyltyrosine
alanyltyrosine: tyrosine source; RN given refers to (L)-isomer. Ala-Tyr : A dipeptide composed of L-alanine and L-tyrosine joined by a peptide linkage. | 2.71 | 3 | 0 | dipeptide | metabolite |
glycyl-l-phenylalanine
glycylphenylalanine: RN given refers to (DL)-isomer. Gly-Phe : A dipeptide formed from glycine and L-phenylalanine residues. | 2.71 | 3 | 0 | dipeptide zwitterion;
dipeptide | human metabolite;
metabolite |
aspartyl-phenylalanine
aspartyl-phenylalanine: metabolite of aspartame; may inhibit angiotensin converting enzyme; RN given refers to all (L)-isomer | 2.1 | 1 | 0 | dipeptide | human blood serum metabolite;
human xenobiotic metabolite |
glycylsarcosine
glycylsarcosine : A dipeptide obtained by formal condensation of the carboxy group of glycine with the amino group of sarcosine. | 2.03 | 1 | 0 | dipeptide zwitterion;
dipeptide | |
diprotin a
[no description available] | 3.27 | 1 | 0 | peptide | |
alanylphenylalanine
alanylphenylalanine: RN given refers to (L-Ala-L-PheAla)-isomer | 2.71 | 3 | 0 | dipeptide | metabolite |
tryptophylglycine
Trp-Gly : A dipeptide formed from L-tryptophan and glycine residues. | 2.41 | 2 | 0 | dipeptide | metabolite |
glycylaspartic acid
glycylaspartic acid: RN given refers to (L)-isomer | 2.41 | 2 | 0 | dipeptide | metabolite |
n-glycylglutamic acid
N-glycylglutamic acid: RN given refers to (L)-isomer. Gly-Glu : A dipeptide formed from glycyl and L-glutamic acid residues. | 2.41 | 2 | 0 | dipeptide | metabolite |
histidylglycine
histidylglycine: RN given refers to all (L)-isomer. His-Gly : A dipeptide formed from L-histidine and glycine residues. | 2.41 | 2 | 0 | dipeptide | metabolite |
valylvaline
valylvaline: RN given refers to (L)-isomer. Val-Val : A dipeptide formed from two L-valine residues. | 2.41 | 2 | 0 | dipeptide | Mycoplasma genitalium metabolite |
maculosin
maculosin: RN refers to (3S-trans)-isomer; isolated from Alternaria alternata; structure given in first source. maculosin : A homodetic cyclic peptide that is a dipeptide composed of L-proline and L-tyrosine joined by peptide linkages. | 2.11 | 1 | 0 | dipeptide;
homodetic cyclic peptide;
phenols;
pyrrolopyrazine | metabolite |
proctolin
proctolin: neurotransmitter in arthropods or invertebrates | 1.98 | 1 | 0 | | |
glycylglutamine
glycylglutamine: inhibitory neuropeptide derived from beta-endorphin; RN given refers to (L)-isomer | 1.98 | 1 | 0 | dipeptide zwitterion;
dipeptide | metabolite;
protective agent |
methotrexate
[no description available] | 2.01 | 1 | 0 | dicarboxylic acid;
monocarboxylic acid amide;
pteridines | abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent |
glycyl-leucyl-phenylalanine
glycyl-leucyl-phenylalanine: an immunostimulatory peptide; RN given refer to all (L)-isomer | 2.03 | 1 | 0 | oligopeptide | |
lysyllysine
lysyllysine: RN given refers to (L-Lys)-isomer. Lys-Lys : A dipeptide formed from two L-lysine residues. | 2.03 | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
n-acetylseryl-leucyl-asparaginyl(phenylalanyl-hydroxyethylamino-prolyl)isoleucyl-valyl methyl ester
N-acetylseryl-leucyl-asparaginyl(phenylalanyl-hydroxyethylamino-prolyl)isoleucyl-valyl methyl ester: inhibitor of HIV Protease; structure given in first source; RN given is for (S-(R*,R*)) isomer | 2.01 | 1 | 0 | | |
h 142
H 142: decapeptide inhibitor of human renin; RN given refers to all L-isomer | 2.01 | 1 | 0 | | |
h 256
H 256: heptapeptide inhibitor of pepsin | 2.01 | 1 | 0 | | |
phenylalanylarginine
phenylalanylarginine: RN given refers to all (L)-isomer. Phe-Arg : A dipeptide composed of L-phenylalanine and L-arginine joined by a peptide linkage. | 1.98 | 1 | 0 | dipeptide | metabolite |
arginylproline
arginylproline: first & second amino acid in substance P sequence; RN given refers to (L)-isomer. Arg-Pro : A dipeptide obtained by formal condensation of the carboxy group of L-arginine with the amino group of L-proline. | 2.1 | 1 | 0 | dipeptide | |
aspartylglycine
Asp-Gly : A dipeptide composed of L-aspartic acid and glycine joined by a peptide linkage. | 2.41 | 2 | 0 | dipeptide | metabolite |
arginylarginine
Arg-Arg : A dipeptide formed from two L-arginine residues. | 2.03 | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
prolyl-tyrosine
prolyl-tyrosine: structure given in first source. Pro-Tyr : A dipeptide formed from L-proline and L-tyrosine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
lysylproline
lysylproline: third & fourth amino acid in substance P sequence. Lys-Pro : A dipeptide formed from L-lysine and L-proline residues. | 2.1 | 1 | 0 | dipeptide | metabolite |
brevianamide f
brevianamide F: isolated from the endophyte from Aspergillus fumigatus associated with Melia azedarach L that could be used to develop a natural eco-friendly herbicide.structure in first source. brevianamide F : A pyrrolopyrazine that is hexahydropyrrolo[1,2-a]pyrazine-1,4-dione bearing an indol-3-ylmethyl substituent at position 3 (the 3S,8aS-diastereomer, obtained by formal cyclocondensation of L-tryptophan and L-proline). | 2.11 | 1 | 0 | dipeptide;
indoles;
pyrrolopyrazine | metabolite |
cirsimaritin
cirsimaritin: has antagonist or partial agonist activity on benzodiazepine receptors. cirsimaritin : A dimethoxyflavone that is flavone substituted by methoxy groups at positions 6 and 7 and hydroxy groups at positions 5 and 4' respectively. | 3.27 | 1 | 0 | dihydroxyflavone;
dimethoxyflavone | |
histidylleucine
His-Leu : A dipeptide formed from L-histidine and L-leucine residues. | 1.98 | 1 | 0 | dipeptide zwitterion;
dipeptide | metabolite |
prolylglutamic acid
Pro-Glu : A dipeptide formed from L-proline and L-glutamic acid residues. | 2.03 | 1 | 0 | dipeptide | metabolite |
cp 71362
[no description available] | 2.01 | 1 | 0 | | |
19-norprogesterone
19-norprogesterone: RN given refers to cpd without isomeric designation | 1.98 | 1 | 0 | corticosteroid hormone | |
mibolerone
mibolerone: prevents estrus in animals & prevents experimental lymphoid leukosis; minor descriptor (80-83); on-line & Index Medicus search NANDROLONE/AA (80-83); RN given refers to (7alpha,17beta)-isomer; structure. mibolerone : An androgen that is nalandrone carrying two methyl substituents at positions 7alpha and 17. | 1.98 | 1 | 0 | 17beta-hydroxy steroid;
3-oxo-Delta(4) steroid | anabolic agent;
androgen |
metribolone
Metribolone: A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.. 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one : A synthetic non-aromatisable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors. | 1.98 | 1 | 0 | 17beta-hydroxy steroid;
3-oxo steroid;
anabolic androgenic steroid | androgen |
arabinose
[no description available] | 2.01 | 1 | 0 | L-arabinose | Escherichia coli metabolite;
mouse metabolite |
naringenin
(S)-naringenin : The (S)-enantiomer of naringenin. | 3.27 | 1 | 0 | (2S)-flavan-4-one;
naringenin | expectorant;
plant metabolite |
galactose
beta-D-galactose : A D-galactopyranose having beta-configuration at the anomeric centre.. beta-D-galactoside : Any D-galactoside having beta-configuration at its anomeric centre. | 2.01 | 1 | 0 | D-galactopyranose | epitope;
mouse metabolite |
glutamyl-glutamic acid
glutamyl-glutamic acid: RN given for (L,L)-isomer. Glu-Glu : A dipeptide composed of two L-glutamic acid units joined by a peptide linkage. | 2.03 | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
cyanidin 3-o-beta-d-glucopyranoside
cyanidin 3-O-beta-D-glucoside : An anthocyanin cation that is a cyanidin cation linked to a beta-D-glucosyl moiety at position 3. | 3.27 | 1 | 0 | anthocyanin cation;
beta-D-glucoside;
monosaccharide derivative | metabolite |
phosphoramidon
phosphoramidon: a membrane metallo-endopeptidase & endothelin-converting enzyme inhibitor; thermolysin inhibitor from culture filtrate of Streptomyces tanashiensis; structure. phosphoramidon : A dipeptide isolated from the cultures of Streptomyces tanashiensis. | 2.01 | 1 | 0 | deoxyaldohexose phosphate;
dipeptide | bacterial metabolite;
EC 3.4.24.11 (neprilysin) inhibitor;
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor |
resveratrol
trans-resveratrol : A resveratrol in which the double bond has E configuration. | 3.27 | 1 | 0 | resveratrol | antioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger |
retinol
Vitamin A: Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of CAROTENOIDS found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.. vitamin A : Any member of a group of fat-soluble retinoids produced via metabolism of provitamin A carotenoids that exhibit biological activity against vitamin A deficiency. Vitamin A is involved in immune function, vision, reproduction, and cellular communication.. all-trans-retinol : A retinol in which all four exocyclic double bonds have E- (trans-) geometry.. retinol : A retinoid consisting of 3,7-dimethylnona-2,4,6,8-tetraen-1-ol substituted at position 9 by a 2,6,6-trimethylcyclohex-1-en-1-yl group (geometry of the four exocyclic double bonds is not specified). | 2.01 | 1 | 0 | retinol;
vitamin A | human metabolite;
mouse metabolite;
plant metabolite |
phosphonoacetohydroxamate
phosphonoacetohydroxamic acid : The hydroxamate of phosphonoacetic acid. | 2.01 | 1 | 0 | hydroxamic acid;
organic phosphonate | |
tacrolimus
Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.. tacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis. | 2.01 | 1 | 0 | macrolide lactam | bacterial metabolite;
immunosuppressive agent |
a 76928
A 76928: a diol with C2-symmetry | 2.01 | 1 | 0 | | |
xk 263
[no description available] | 2.01 | 1 | 0 | | |
phenylalanyl-prolyl-arginine
[no description available] | 2.01 | 1 | 0 | oligopeptide | |
isoleucylvaline
isoleucylvaline: RN given refers to all (L)-isomer. Ile-Val : A dipeptide formed from L-isoleucine and L-valine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
aspartyl-aspartic acid
aspartyl-aspartic acid: do not confuse with cyclo(Asp-Asp). Asp-Asp : A dipeptide formed from two L-aspartic acid units. | 2.03 | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
Phe-Tyr
Phe-Tyr : A dipeptide formed from L-phenylalanine and L-tyrosine residues. | 2.42 | 2 | 0 | dipeptide | metabolite |
caffeic acid
trans-caffeic acid : The trans-isomer of caffeic acid. | 3.27 | 1 | 0 | caffeic acid | geroprotector;
mouse metabolite |
n-glycylalanine
Gly-Ala : A dipeptide formed from glycine and L-alanine residues. | 2.41 | 2 | 0 | dipeptide | metabolite |
glycylvaline
glycylvaline: RN given refers to (DL)-isomer | 1.98 | 1 | 0 | dipeptide | human metabolite |
glycylproline
Gly-Pro : A dipeptide consisting of L-proline having a glycyl residue attached to its alpha-amino group. | 2.71 | 3 | 0 | dipeptide zwitterion;
dipeptide | metabolite |
glycyllysine
glycyllysine: RN given refers to (L)-isomer. Gly-Lys : A dipeptide formed from glycine and L-lysine residues. | 2.7 | 3 | 0 | dipeptide | metabolite |
leucine hydroxamate
leucine hydroxamate: RN given refers to (S)-isomer | 2.01 | 1 | 0 | | |
methionyltryptophan
Met-Trp : A dipeptide formed from L-methionine and L-tryptophan residues. | 2.1 | 1 | 0 | dipeptide | metabolite |
sitagliptin
sitagliptin : A triazolopyrazine that exhibits hypoglycemic activity. | 3.27 | 1 | 0 | triazolopyrazine;
trifluorobenzene | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
environmental contaminant;
hypoglycemic agent;
serine proteinase inhibitor;
xenobiotic |
quercetin
[no description available] | 3.27 | 1 | 0 | 7-hydroxyflavonol;
pentahydroxyflavone | antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger |
apigenin
Chamomile: Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia. | 3.27 | 1 | 0 | trihydroxyflavone | antineoplastic agent;
metabolite |
luteolin
[no description available] | 3.27 | 1 | 0 | 3'-hydroxyflavonoid;
tetrahydroxyflavone | angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist |
kaempferol
[no description available] | 3.27 | 1 | 0 | 7-hydroxyflavonol;
flavonols;
tetrahydroxyflavone | antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite |
genistein
[no description available] | 3.27 | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor |
hispidulin
hispidulin : A monomethoxyflavone that is scutellarein methylated at position 6. | 3.27 | 1 | 0 | monomethoxyflavone;
trihydroxyflavone | anti-inflammatory agent;
anticonvulsant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
plant metabolite |
methylestrenolone
methylestrenolone: was MH 1963-92; METHYLESTRENOLONE & METHYLNORTESTOSTERONE were see NORMETHANDROLONE 1963-92; use ESTRENES to search NORMETHANDROLONE 1966-92 | 1.98 | 1 | 0 | steroid | estrogen |
enalapril
Enalapril: An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE.. enalapril : A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration). | 1.97 | 1 | 0 | dicarboxylic acid monoester;
dipeptide | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug |
enalaprilat anhydrous
Enalaprilat: The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.. enalaprilat dihydrate : The dihydrate form of enalaprilat, an angiotensin-converting enzyme (ACE) inhibitor that is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is administered by intravenous injection.. enalaprilat (anhydrous) : Enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is given by intravenous injection, usually as the dihydrate. | 1.97 | 1 | 0 | dicarboxylic acid;
dipeptide | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
imidapril
imidapril: structure given in first source. imidapril : A member of the class of imidazolidines that is (4S)-1-methyl-2-oxoimidazolidine-4-carboxylic acid in which the hydrogen of the imidazolidine nitrogen has been substituted by (1S)-1-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}ethyl group. It is the prodrug for imidaprilat, an ACE inhibitor used for the treatment of chronic heart failure. | 1.97 | 1 | 0 | dicarboxylic acid monoester;
dipeptide;
ethyl ester;
imidazolidines;
N-acylurea;
secondary amino compound | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
imidaprilat
imidaprilat: structure given in first source; active metabolite of imidapril. imidaprilat : A member of the class of imidazolidines that is imidapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of imidapril used to treat hypertension. | 1.97 | 1 | 0 | dicarboxylic acid;
dipeptide;
imidazolidines;
N-acylurea;
secondary amino compound | antihypertensive agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
pepstatin
pepstatin: inhibits the aspartic protease endothiapepsin | 2.01 | 1 | 0 | pentapeptide;
secondary carboxamide | bacterial metabolite;
EC 3.4.23.* (aspartic endopeptidase) inhibitor |
streptomyces pepsin inhibitor
[no description available] | 2.01 | 1 | 0 | | |
alanylalanine
L-alanyl-L-alanine : A dipeptide consisting of two L-alanine units joined by a peptide linkage. | 2.41 | 2 | 0 | dipeptide zwitterion;
dipeptide | Mycoplasma genitalium metabolite |
phenylalanylalanine
phenylalanylalanine: RN given refers to (L)-isomer. Phe-Ala : A dipeptide formed from L-phenylalanine and L-alanine residues. | 2.03 | 1 | 0 | dipeptide zwitterion;
dipeptide | metabolite |
alpha-aspartylalanine
alpha-aspartylalanine: found in pig brain. Asp-Ala : A dipeptide formed from L-alpha-aspartyl and L-valine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
cp 81282
CP 81282: structure given in first source; inhibits human renin and endothiapepsin | 2.01 | 1 | 0 | | |
alanyltyrosine
Tyr-Ala : A dipeptide formed from L-tyrosine and L-alanine residues. | 2.41 | 2 | 0 | dipeptide | metabolite |
prolylglycine
prolylglycine: RN given refers to (L)-isomer. L-prolylglycine : A dipeptide consisting of glycine having an L-prolyl group attached to its alpha-amino nitrogen. | 2.41 | 2 | 0 | dipeptide zwitterion;
dipeptide | |
arginyllysine
Arg-Lys : A dipeptide formed from L-arginyl and L-leucine residues. | 2.03 | 1 | 0 | dipeptide | metabolite |
vildagliptin
[no description available] | 3.27 | 1 | 0 | amino acid amide | |
phenylalanylglycine
phenylalanylglycine: RN given refers to (DL)-isomer. Phe-Gly : A dipeptide formed from L-phenylalanine and glycine residues. | 2.41 | 2 | 0 | dipeptide | metabolite |
leucyl-phenylalanine
Leu-Phe : A dipeptide formed from L-leucine and L-phenylalanine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
glutamylalanine
Glu-Ala : A dipeptide formed from L-alpha-glutamyl and L-alanine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
glutaminyl-glycine
Gln-Gly : A dipeptide formed from L-glutamine and glycine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
methionylglycine
methionylglycine: RN given refers to (L)-isomer. Met-Gly : A dipeptide formed from L-methionine and glycine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
phenylalanylphenylalanine
Phe-Phe : A dipeptide formed from two L-phenylalanine residues. | 1.98 | 1 | 0 | dipeptide;
L-aminoacyl-L-amino acid zwitterion | human blood serum metabolite;
Mycoplasma genitalium metabolite |
histidylhistidine
histidylhistidine: RN given for L-,L-isomer | 2.03 | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
valylleucine
valylleucine: RN given refers to all L-isomer. Val-Leu : A dipeptide formed from L-valine and L-leucine residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
phenylalanyl-valine
Val-Phe : A dipeptide formed from L-valine and L-phenylalanine residues. | 2.42 | 2 | 0 | dipeptide | metabolite |
alanylglycine
[no description available] | 1.98 | 1 | 0 | dipeptide zwitterion;
dipeptide | metabolite |
valyltyrosine
valyltyrosine: from sardine muscle hydrolyzate. Val-Tyr : A dipeptide formed from L-valine and L-tyrosine residues. | 2.42 | 2 | 0 | dipeptide | metabolite |
alpha-glutamyltryptophan
Trp-Glu : A dipeptide formed from L-tryptophan and L-glutamic acid residues. | 1.98 | 1 | 0 | dipeptide | metabolite |
lysylglutamic acid
lysylglutamic acid: a geroprotective agent. Lys-Glu : A dipeptide formed from L-lysine and L-glutamic acid residues. | 2.03 | 1 | 0 | dipeptide | metabolite |
Ala-Lys
Ala-Lys : A dipeptide obtained by formal condensation of the carboxy group of L-alanine with the alpha-amino group of L-lysine. | 2.03 | 1 | 0 | dipeptide | marine metabolite |
valyl-valyl-valine
[no description available] | 2.03 | 1 | 0 | peptide | |
phenylalanylproline
Phe-Pro : A dipeptide formed from L-phenylalanine and L-proline residues. | 2.51 | 2 | 0 | dipeptide | metabolite |
lysylglycine
lysylglycine: structure in first source. Lys-Gly : A dipeptide formed from L-lysine and glycine residues. | 2.41 | 2 | 0 | dipeptide | metabolite |
glycylhistidine
glycylhistidine: RN given refers to (L)-isomer. Gly-His : A dipeptide composed of glycine and L-histidine joined by a peptide linkage. | 2.41 | 2 | 0 | dipeptide zwitterion;
dipeptide | metabolite |
prolylisoleucine
prolylisoleucine: RN refers to (L)-isomer. Pro-Ile : A dipeptide formed from L-proline and L-isoleucine residues. | 2.11 | 1 | 0 | dipeptide | metabolite |
isoleucyl-tyrosine
isoleucyl-tyrosine: a dipeptide with antihypertensive effect. Ile-Tyr : A dipeptide formed from L-isoleucine and L-tyrosine residues. | 2.7 | 3 | 0 | dipeptide | metabolite |
prolyl-serine
Pro-Ser : A dipeptide formed from L-proline and L-serine residues. | 2.03 | 1 | 0 | dipeptide | metabolite |
valyl-prolyl-proline
Val-Pro-Pro : A tripeptide composed of L-valine and two L-proline units joined by peptide linkages. | 2.11 | 1 | 0 | tripeptide | metabolite |
prolylvaline
Val-Pro : A dipeptide formed from L-valine and L-proline residues. | 2.42 | 2 | 0 | dipeptide | metabolite |
isoleucyl-prolyl-proline
[no description available] | 2.11 | 1 | 0 | oligopeptide | |
linagliptin
Linagliptin: A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.. linagliptin : A xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes. | 3.27 | 1 | 0 | aminopiperidine;
quinazolines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent |
alogliptin
alogliptin: structure in first source. alogliptin : A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes. | 3.27 | 1 | 0 | nitrile;
piperidines;
primary amino compound;
pyrimidines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent |
gosogliptin
[no description available] | 3.27 | 1 | 0 | amino acid amide | |
prolyl-proline
Pro-Pro : A dipeptide formed from two L-proline residues. | 2.03 | 1 | 0 | dipeptide | human urinary metabolite;
Mycoplasma genitalium metabolite |
teneligliptin
[no description available] | 3.27 | 1 | 0 | amino acid amide | |
trelagliptin
trelagliptin: a dipeptidyl peptidase IV inhibitor | 3.27 | 1 | 0 | benzenes;
nitrile | |
anagliptin
anagliptin: anagliptin hydrochloride salt is the active compound | 3.27 | 1 | 0 | amino acid amide | |
mk-3102
[no description available] | 3.27 | 1 | 0 | pyrrolopyrazole | |